dc.creatorOrtíz Ramírez, Mario
dc.date.accessioned2013-11-12T18:53:37Z
dc.date.accessioned2023-07-19T14:05:48Z
dc.date.available2013-11-12T18:53:37Z
dc.date.available2023-07-19T14:05:48Z
dc.date.created2013-11-12T18:53:37Z
dc.date.issued2011
dc.identifierhttp://repository.uaeh.edu.mx/bitstream/handle/123456789/13984
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/7705198
dc.description.abstractPharmacovigilance is defined as watchfulness in guarding against danger from drugs or providing for safety of drugs. It can also be a dedicated department whose role is to monitor toxicity and safety of drugs both in the developmental phase and post marketing. A working group on Pharmacovigilance aims to develop workable operating procedures for the publicly funded research community for reporting, monitoring and managing adverse reactions and events that will satisfy the requirements of the Medicines for Human Use (Clinical Trials) Regulations. It is also envisaged that the group will review and evaluate information from healthcare providers and patients on the adverse effects of medications, biological products, herbalism and traditional medicines.
dc.languageen
dc.subjectResearch Subject Categories::MEDICINE
dc.titlePharmacovigilance of Psychoactive Medications in a Mexican Psychiatric Hospital
dc.typePresentation


Este ítem pertenece a la siguiente institución